How 3D Cell Models Will Shape the Future of Drug Discovery
- Mar 07, 2023
Target discovery and drug development rely heavily on 2D cell and animal models to decipher efficacy and toxic effect of drug candidates. Yet, 90% of candidates fail to make it past phase III…
Recent posts
A case study for assay-ready patient-derived organoids (PDOs) and high-throughput 3D imaging to advance drug discovery
- Feb 10, 2023
Introduction – the problem. The average cost of bringing a new drug to the clinic is around $1 billion according to a study…
3D organoids and automation of complex cell assays [Podcast]
- Jan 27, 2023
As we enter the era of sophisticated drug discovery with gene therapy and personalized medicine, we need to be prepared to study…
Celebrating the art of science: A D+I interview with Daniele Tortorella
- Nov 23, 2022
At Molecular Devices, we cultivate a culture where associates around the world are encouraged to bring their full, authentic selves to…
